 |
Conference papers
Validation of GATE 6.1 for targeted radiotherapy of metastic melanoma using 131I-labeled benzamide
Abstract : The GATE 6.1 Monte Carlo simulation platform based on the GEANT4 toolkit is in constant improvement for dosimetric calculations. Here, we explore its use for calculating internal absorbed dose distribution in mice for the treatment of malignant melanoma after injection of a new specific radiopharmaceutical labeled with iodine 131. We estimate the dosimetric accuracy of GATE 6.1, by calculating first S values and by comparing them and absorbed doses to organswith EGSnrc for a digital mouse phantom and a CT scan based mouse phantom.
Cited literature [1 references]
http://hal.in2p3.fr/in2p3-00703187
Contributor : Jeanine Pellet Connect in order to contact the contributor
Submitted on : Friday, June 1, 2012 - 10:22:55 AM
Last modification on : Thursday, December 16, 2021 - 2:10:14 PM
Long-term archiving on: : Sunday, September 2, 2012 - 2:22:25 AM
Contributor : Jeanine Pellet Connect in order to contact the contributor
Submitted on : Friday, June 1, 2012 - 10:22:55 AM
Last modification on : Thursday, December 16, 2021 - 2:10:14 PM
Long-term archiving on: : Sunday, September 2, 2012 - 2:22:25 AM
Files
Perrot_MCTP2012.pdf
Files produced by the author(s)